Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Nov 04, 2016 $0.89 $0.94 $0.88 $0.90 175 600
Nov 03, 2016 $0.99 $1.00 $0.88 $0.90 112 500
Nov 02, 2016 $1.02 $1.07 $0.97 $1.00 188 900
Nov 01, 2016 $1.03 $1.08 $1.00 $1.00 161 500
Oct 31, 2016 $1.03 $1.10 $0.98 $1.03 245 500
Oct 28, 2016 $1.07 $1.10 $1.01 $1.06 218 500
Oct 27, 2016 $1.15 $1.18 $1.00 $1.07 270 500
Oct 26, 2016 $1.25 $1.26 $1.13 $1.14 235 600
Oct 25, 2016 $1.24 $1.26 $1.22 $1.25 127 200
Oct 24, 2016 $1.32 $1.35 $1.21 $1.22 358 400
Oct 21, 2016 $1.29 $1.37 $1.29 $1.32 317 300
Oct 20, 2016 $1.26 $1.32 $1.25 $1.28 121 300
Oct 19, 2016 $1.28 $1.32 $1.25 $1.25 345 500
Oct 18, 2016 $1.28 $1.37 $1.25 $1.27 355 900
Oct 17, 2016 $1.24 $1.39 $1.23 $1.27 335 800
Oct 14, 2016 $1.37 $1.43 $1.21 $1.24 346 100
Oct 13, 2016 $1.47 $1.47 $1.39 $1.41 194 700
Oct 12, 2016 $1.55 $1.62 $1.45 $1.48 265 100
Oct 11, 2016 $1.65 $1.70 $1.58 $1.58 216 400
Oct 10, 2016 $1.63 $1.64 $1.60 $1.62 83 100
Oct 07, 2016 $1.65 $1.69 $1.60 $1.64 81 700
Oct 06, 2016 $1.72 $1.73 $1.62 $1.64 125 200
Oct 05, 2016 $1.67 $1.74 $1.67 $1.72 73 900
Oct 04, 2016 $1.75 $1.75 $1.65 $1.67 113 600
Oct 03, 2016 $1.76 $1.77 $1.70 $1.75 67 300
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT